As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Section Editor Isabella Annesi-Maesano about natural disasters and respiratory health, as discussed in her review article in this issue of the ERJ: https://doi.org/10.1183/13993003.02563-2024

Cite this podcast as: ERJ Podcast October 2025: Natural disasters and respiratory health. Eur Respir J 2025; 66: 25E6604 [https://doi.org/10.1183/13993003.E6604-2025]

"Although we have learned a lot about this disease [...] we still need to improve awareness. That means colleagues have to think that the patient may have pulmonary hypertension."

In this episode, Dorina Esendagli (the Monograph's Early Career Member representative) meets with Gabor Kovacs to discuss the recent Monograph on "Pulmonary Hypertension", which he co-Guest Edited with Athénaïs Boucly and Robin Condliffe. Gabor explains how the Monograph addresses diagnosis and can be used to guide the nonspecialist, highlights the importance of the multidisciplinary team, and brings important areas of future research into focus.

As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Marcus Mall about neutrophil-derived biomarkers in bronchiectasis, as discussed in his review article in this issue of the ERJ: https://doi.org/10.1183/13993003.00081-2025

Correction: At 5 min 54 s in this podcast, in response to a question from D. Sin regarding the dosing of azithromycin, M. Mall mistakenly replied that “For the immunomodulatory effects, it would be a standard long-term therapy with a three times per day regimen.” He meant to say “three times per week”. We apologise for this error.

Cite this podcast as: ERJ Podcast September 2025: Neutrophil-derived biomarkers in bronchiectasis. Eur Respir J 2025; 55: 25E6603. [https://doi.org/10.1183/13993003.E6603-2025]

As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Winfried Randerath (Bethanien Hospital, Clinic of Pneumology and Allergology, Centre for Sleep Medicine and Respiratory Care, Institute of Pneumology at the University of Cologne, Solingen, Germany) about the European Respiratory Society and European Sleep Research Society statement on the treatment of central sleep apnoea with adaptive servo-ventilation in this issue of the ERJ: https://doi.org/10.1183/13993003.00263-2025

Cite this podcast as: ERJ Podcast August 2025: Treatment of central sleep apnoea with adaptive servo-ventilation. Eur Respir J 2025; 66: 25E6602 [doi.org/10.1183/13993003.E6602-2025].

“We really need to celebrate the exciting times in asthma but also focus on the advocacy for improving outcomes in research and in clinical practice”

Leading asthma experts David Jackson, Vanessa McDonald and Ian Pavord meet with Monograph Editorial Board member Dorina Esendagli to discuss their 500-page authoritative guide to the latest developments in the field. They discuss pathophysiology, treatable traits, biomarkers, comorbidities, the importance of the multidisciplinary team, and the personal experiences that gave them a genuine passion for helping asthma patients.

As part of the July issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Walter McNicholas (School of Medicine and the Conway Research Institute, University College Dublin, and Department of Respiratory and Sleep Medicine, St Vincent’s Hospital Group, Dublin, Ireland) about the challenges of implementing European national driving regulations for obstructive sleep apnoea, as discussed in Prof. McNicholas’ article in this issue of the ERJ: https://doi.org/10.1183/13993003.02484-2024

Cite this podcast as: ERJ Podcast July 2025: Implementation of European national driving regulations for OSA. Eur Respir J 2025; 66: 25E6601 [https://doi.org/10.1183/13993003.E6601-2025].

As part of the January issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Dr Peter Gibson about distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma.

As part of the June issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Bruno Crestani about a series of articles published in the June issue of the ERJ on mechanistic studies in interstitial lung disease: building translational bridges in IPF research.

As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marius Hoeper about the efficacy and safety of the activin signalling inhibitor sotatercept in a pooled analysis of PULSAR and STELLAR studies.

As part of the April issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Dr Fernanda Almeida about the CHOICE multicentre, open-label randomised clinical trial.